Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTRU
4876
DELISTED
Vitru Limited Common Shares
VTRU
| $276K | ﹤0.01% |
+17,224
| New | +$275K |
|
4877
SCYNEXIS
SCYX
$54.9M
| $276K | ﹤0.01% |
+11,687
| New | +$273K |
|
4878
FuelCell Energy
FCEL
$1.54B
| $276K | ﹤0.01% |
4,255
+2,310
| +119% | +$157K |
|
4879
Capitol Federal Financial
CFFN
$1.07B
| $276K | ﹤0.01% |
+44,652
| New | +$278K |
|
4880
German American Bancorp
GABC
$1.86B
| $275K | ﹤0.01% |
10,131
-22,364
| -69% | -$651K |
|
|
ONTF
4881
DELISTED
ON24
ONTF
| $275K | ﹤0.01% |
+33,870
| New | +$281K |
|
|
CELL
4882
DELISTED
PhenomeX Inc. Common Stock
CELL
| $275K | ﹤0.01% |
560,701
+88,821
| +19% | +$72.7K |
|
4883
Fidelity High Dividend ETF
FDVV
$10.4B
| $273K | ﹤0.01% |
+6,858
| New | +$264K |
|
4884
Genasys
GNSS
$70.6M
| $272K | ﹤0.01% |
104,807
-27,956
| -21% | -$77.2K |
|
4885
Bogota Financial
BSBK
$116M
| $272K | ﹤0.01% |
33,367
-966
| -3% | -$8.16K |
|
|
BICK
4886
DELISTED
First Trust BICK Index Fund
BICK
| $271K | ﹤0.01% |
9,961
-1,539
| -13% | -$40.2K |
|
4887
CBIZ
CBZ
$2.97B
| $270K | ﹤0.01% |
5,067
-51,653
| -91% | -$2.66M |
|
4888
CALL
Burford Capital
BUR
$949M
| $269K | ﹤0.01% |
+22,100
| New | +$286K |
|
|
CTLT
4889
CALL
DELISTED
CATALENT, INC.
CTLT
| $269K | ﹤0.01% |
6,200
-175,600
| -97% | -$7.71M |
|
|
GAN
4890
DELISTED
GAN Ltd
GAN
| $269K | ﹤0.01% |
163,810
-370,706
| -69% | -$528K |
|
|
JWN
4891
PUT
DELISTED
Nordstrom
JWN
| $268K | ﹤0.01% |
13,100
| – | – |
|
4892
PUT
Cognizant
CTSH
$28.7B
| $268K | ﹤0.01% |
4,100
-5,700
| -58% | -$353K |
|
4893
Amkor Technology
AMKR
$12.9B
| $268K | ﹤0.01% |
8,995
-45,585
| -84% | -$1.11M |
|
4894
PUT
Arbor Realty Trust
ABR
$938M
| $267K | ﹤0.01% |
18,000
| – | – |
|
4895
Pixelworks
PXLW
$41.8M
| $267K | ﹤0.01% |
12,844
-15,454
| -55% | -$298K |
|
4896
CALL
BioXcel Therapeutics
BTAI
$22.5M
| $266K | ﹤0.01% |
+2,500
| New | +$832K |
|
|
NKLA
4897
DELISTED
Nikola Corporation Common Stock
NKLA
| $266K | ﹤0.01% |
+6,433
| New | +$177K |
|
4898
PUT
TE Connectivity
TEL
$58.8B
| $266K | ﹤0.01% |
1,900
+300
| +19% | +$37.9K |
|
4899
PUT
Roblox
RBLX
$27.3B
| $266K | ﹤0.01% |
6,600
-11,800
| -64% | -$474K |
|
|
SIFY
4900
Sify Technologies
SIFY
$1.07B
| $266K | ﹤0.01% |
23,575
-6,272
| -21% | -$51.6K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.